Allianz Asset Management Gmb H Meridian Bioscience Inc Transaction History

Allianz Asset Management Gmb H

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $378,385 - $504,885	-15,932 Reduced 49.3%	16,384 $498,000
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $630,033 - $849,930	-31,549 Reduced 49.4%	32,316 $838,000
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $4.2 Million - $5.2 Million	-240,532 Reduced 79.02%	63,865 $1.3 Million
Q3 2021 Nov 10, 2021	BUY	$17.35 - $22.5 $100,820 - $130,747	5,811 Added 1.95%	304,397 $5.86 Million
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $583,487 - $917,511	32,398 Added 12.17%	298,586 $6.62 Million
Q1 2021 May 13, 2021	BUY	$19.76 - $29.89 $4.55 Million - $6.88 Million	230,088 Added 637.36%	266,188 $6.99 Million
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $175,955 - $242,288	-11,186 Reduced 23.66%	36,100 $675,000
Q3 2020 Nov 13, 2020	SELL	$13.54 - $26.41 $535,317 - $1.04 Million	-39,536 Reduced 45.54%	47,286 $803,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $601,774 - $1.79 Million	76,757 Added 762.61%	86,822 $2.02 Million
Q3 2016 Apr 17, 2019	BUY	N/A	10,065	10,065 $194,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.